Markham C Luke (Markham Luke)

Years Active: 2021-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew Clerman, Markham C Luke
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease. Annals of internal medicine 177 (1) (2024)
Andrew Clerman, Markham C Luke
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease. Annals of internal medicine 177 (1) (2024)
Elham Amini, Simon M Berger, Uta Schilling, Yuanyuan Jiao, Mong-Jen Chen, Sagar Bachhav, Sandra M Baumstein, Yufei Tang, Mohammed Al-Humiari, Carmen E Leon Astudillo, Stefanie Drescher, Teresa Iley, Jagdeep Shur, Robert Price, Cynthia Carrasco, Denise S Conti, Renishkumar Delvadia, Oluwamurewa Oguntimein, Kimberly Witzmann, Mohammad Absar, Markham C Luke, Susan Boc, Sneha Dhapare, Bhawana Saluja, Elizabeth Bielski, Bryan Newman, Jürgen B Bulitta, Guenther Hochhaus
Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays. Molecular pharmaceutics (2023)
Saeid Raofi, Minori Kinjo, Dajun Sun, Zhichuan Li, Heather Boyce, Karthika Natarajan, Mitchell Frost, Liang Zhao, Markham C Luke, Robert Lionberger, Debra Kelsh, Myong-Jin Kim
Particle size affects pharmacokinetics of milled oxycodone hydrochloride tablet products following nasal insufflation in nondependent, recreational opioid users. Clinical and translational science 14 (5) (2021)

Markham C Luke.css-eqlu8i{font-size:small;padding-left:4px;} (Markham Luke)